相关实验视频

Updated: May 7, 2026

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.2K

在患有复发性耐火性多发性骨髓瘤的患者中,对MEDI2228,BCMA向的ADC进行第1期首次人体研究

Meletios A Dimopoulos1, Magdalini Migkou1, Manisha Bhutani2

  • 1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.

Leukemia & lymphoma
|October 15, 2024
PubMed
概括

抗体药物联合体MEDI2228在复发/耐药多发性骨髓瘤患者中显示出有效性. 然而,显著的眼部毒性限制了其进一步的发展.

关键词:
抗体药物联合体的抗体.在B细胞成熟抗原.NCT0348952525 美国国家航空公司三重耐火性多发性骨髓瘤

更多相关视频

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

14.3K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

37

相关概念视频

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...